<IPO>AB&B BIO-TECH-B (02627.HK) Said to Be Priced at Lower Limit of Offer Price; Group B Subscribers Who Purchase Most Shrs to Receive Max. 2 Lots
Vaccine company AB&amp;B BIO-TECH-B (02627.HK) will be listed tomorrow (8th), with an entry...
Vaccine company AB&B BIO-TECH-B (02627.HK) will be listed tomorrow (8th), with an entry fee for a board lot of 200 shares of $3,131.26.
'Group B' investors spent over $26.18 million to subscribe for a maximum of 8,361 lots, with a maximum allocation of only two lots, requiring a subscription of 4,500 lots to secure one lot, according to broker data.
However, Reuters' IFR quoted sources as saying that AB&B BIO-TECH-B will price at the lower limit of its offer price at $12.9 per share, and is not expected to exercise the share issuance adjustment right, with a final fundraising amount of approx. $431 million.
(HK stocks quote is delayed for at least 15 mins.)
Disclaimer: The views in this article are from the original Creator and do not represent the views or position of Hawk Insight. The content of the article is for reference, communication and learning only, and does not constitute investment advice. If it involves copyright issues, please contact us for deletion.
